Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Publications

Emerging Infectious Diseases (EID)

Back To Top

Other References

  • World Health Organization. Global leishmaniasis update, 2006–2015: a turning point in leishmaniasis surveillance. Wkly Epidemiol Rec 2017;92:557-65.
  • Heras-Mosteiro J, Monge-Maillo B, Pinart M, et al. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2017;12:CD005067.
  • Herwaldt BL. Protozoa and helminths. In Wooley DW, Byers KB (eds.). Biological Safety: Principles and Practices. 5th ed. Washington, DC: American Society for Microbiology, 2017:105-45.
  • Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microb Rev 2001;14:659-88.
  • Aronson, N., Herwaldt, B.,et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 2016;63:e202-e264.
  • Karimkhani C, Wanga V, Coffeng LE, Naghavi P, Dellavalle RP, Naghavi M. Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 2016;16:584-91.
  • Fletcher K, Issa R, Lockwood DN. Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the Hospital for Tropical Diseases, London. PLoS One 2015;10:e0121418.
  • Blum J, Buffet P, Visser L, et al. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. J Travel Med 2014;21:116-29.
  • van Griensven J, Carrillo E, Lopez-Velez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 2014;20:286-99.
  • Reveiz L, Maia-Elkhoury ANS, Nicholls RS, Sierra Romero GA, Yadon ZE. Interventions for American cutaneous and mucocutaneous Leishmaniasis: a systematic review update. PLoS One 2013;8:e61843.
  • Clarke CF, Bradley KK, Wright JH, Glowicz J. Emergence of autochthonous cutaneous leishmaniasis in northeastern Texas and southeastern Oklahoma. Am J Trop Med Hyg 2013;88:157-61.
  • Murray HW. Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg 2012;86:434-40.
  • Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:e35671.
  • WHO. Control of the leishmaniases. World Health Organization technical report series 2010:xii-xiii, 1–186, back cover.
  • Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005;366:1561-77.
  • Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.

Back To Top

TOP